GS

Gurnam Singh

Active Director Director DIN 08038958
DIN 08038958 First appointment Feb 2018 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Feb 2018
Shareholding value Locked Premium profile

About Gurnam Singh

Gurnam Singh has 8 years in corporate governance. Holds Director role. Currently with 1 company, including Ivomax Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08038958
Primary Designation Director
First Appointment 28 Feb 2018
Oldest Company Age 8 yrs

Current companies

Company Designation Appointment Founded Status
Ivomax Pharma Private Limited U24304CH2018PTC041881
Director 28 Feb 2018 2018 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ivomax Pharma Private Limited
Premium access

Shareholding and investment profile for Gurnam Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gurnam Singh

Gurnam Singh has 8 years in corporate governance. Holds Director role. Currently with 1 company, including Ivomax Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Gurnam Singh is associated with 1 company as Director.

Gurnam Singh has expertise in General Business.

Gurnam Singh has 8 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available